CYSTIC FIBROSIS Flashcards

1
Q

essentials for Diagnosis:

A
  • chronic obstructive pulmonary disease in childhood and early adulthood
  • positive family history
  • sweat chloride concentration > 80 mEq/L in adult on 2 occasions
  • pancreatic insufficiency, especially in children
  • chronic pseudomonas aeruginosa or staphylococcus aureus bronchitis and bronchiectasis with recurrent exacerbation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

cystic fibrosis: definition and epidemiology

A
  • > generalized autosomal recessive disorder of the exocrine glands
  • > about on in 2500 caucasians is affected, and one in 25 is carrier of the cystic fibrosis gene
  • mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene result in alterations un the chloride transport and water reflux across the apical surface of the epithelial cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

CF: how are the exocrine glands affected?

A

-> almost all are affected by secretion of an abnormal mucus that obstructs glands and ducts in various organs.
- obstruction relus in dilation of the secretory glands and eventual damage to exocrine tissue.
-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

CF: how is the mucocilliary function?

A

-> in the respiratory tract, inadequate hydration of the tracheobronchial epithelium impairs mucocilliary function.
the sputum is thick and viscous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CF: pulmonary manifestations:

A

acute and chronic bronchitis
bronchiectasis
pneumonia
atelectasis
peribronchial and parenchymal scarring
pneumothorax and mild hemoptysis are common
cor pulmonale occurs in advanced cases and means poor prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

CF: most common disorder in? (race)

A

-> most common fatal hereditary disorder of caucasians in USA and is the most common cause of chronic lung disease in children and young adults.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CF: clinical findings

A
  • > diagnosis should be suspected in young adults presenting with a history of chronic lung disease (especially bronchiectasis), pancreatitis or infertility;
  • > cough, exercice intolerance and recurrent pneumonie are typical
  • > Steatorrhhea is common
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CF: physical examination:

A
  • > digital clubbing, increased anteroposterior chest diameter, hyper resonance to percussion and basilar crackles
  • > nasla polyps occur as many as 15% of patients with CF
  • > nearly all men with cf have congenial bilateral absence of the vas deferens with azoospermia
  • > patients with cf have an increased risk of malignancies of the gastrointestinal tract.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CF: laboratory findings: arterial blood gas studies; pulmonary function studies…

A
  • > arterial blood gas studies: hypoxemia
  • > pulmonary function studies: reduction in forced vital capacity, airflow rates and total lung capacity.
  • > Air trapping and reduction in pulmonary diffusing capacity are common
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CF: laboratory findings: what characterized advanced disease

A

-> a mixed obstructive and restrictive pattern of dysfunction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

CF: Imaging: what do you see in the early disease?

A

-> hyperinflation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

CF: Imaging: what may be seen separately and in various combinations?

A

-peribronchial cuffing, mucus plugging, bronchiectasis, increased interstitial markings, small rounded peripheral opacities and focal atelectasis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CF: special examinations: what does the sweat test reveals and in adults?

A
  • > the pilocarpine iontophoresis “ sweat test “ reveals elevated sodium and chloride levels (>60 mEq/L) in the sweat of patients with CF
  • > values higher than >80 mEq/L are diagnostic in adults
  • > two separate tests on consecutive days are required
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

CF: TTT: what are the antibiotics used for? what common bacteria?

A
  • > are used to treat active airway infections based on results of culture and susceptibility testing of sputum
  • S aureus and variants of pseudomonas aerugingsa are commonly present
  • Haemophilus influenza is occasionally isolated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

TTT: use of aerosolized antibiotics for what? and is it useful?

A
  • > for prophylaxis or ttt of lower respiratory tract infections
  • > sometimes useful with pt with CF
  • > some studies demonstrated reduced exacerbation in pt chronically affecter with P. aerugingsa.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

TTT: what are inhaled aerosols, chest physiotherapy and inhaled bronchodilators used for?

A

-> promote clearance of airway secretions

17
Q

TTT: what does chest physiotherapy include?

A

-> daily postural drainage and percussion by a caregiver, self performed postural drainage, positive expiratory pressure (PEP) mask therapy and other breathing technics.

18
Q

TTT:what should be avoided?

A
  • > cough suppressants

- > chronic use of mucolytic agents such as acetylcysteine is of no proved benefit

19
Q

TTT: what vaccine?

A

against pneumococcal infection and annual influenza

20
Q

TTT: what antibiotic has shown to improve height, weight, and pulmonary function in children?

A

alternate day prednisone (2mg/kg for 4 years)

21
Q

TTT: what the only definitive ttt for Cf? what’s the 3 y survival?

A
  • > lung transplantation

- > the 3 years survival rate after transplant is 57%

22
Q

TTT: what are the concerns that render transplantation for cf controversial?

A

the high cost of transplant and the high frequency of obliterative bronchiolitis in survivors

23
Q

TTT: recombinant human deoxyribonuclease?

A

cleaves the extracellular dna from neutrophils in sputum rendering it less viscous and easier to clear.
aerosol dose of 2.5 mg once or twice daily
(annual cost 12000$)

24
Q

TTT: dornase alfa is indicated for? limited to who? Results in? side effect?

A
  • > only daily maintenance tttt of pat with cf as a supplement to standard therapy.
  • > limited to pat over the age of 5y and those with FVC value greater than 40% of predicted
  • > results in reduced frequency of respiratory tract infection, reduced need for parenteral antibiotics and shorter hospitalization
  • > side effects: pharyngitis, laryngitis and voice alterations are common
25
Q

CF: Prognosis

A
  • > longevity of patients with cf is increasing and median survival age is now 29y
  • > few pat survives beyond 35y
  • > death from pulmonary complications : pneumonia, pneumothorax or hemoptysis or as a result of terminal chronic respiratory failure or cor pulmonale